Boston -- Northeastern University scientists in Boston say they have developed an early-stage, highly accurate cancer-screening technology.
Professor Max Diem, who developed the the procedure, said it can determine within seconds whether a cell is cancerous, precancerous or normal.
The scientists said the technology, for which there is a patent pending, automatically captures a "fingerprint" of the cell's biochemical composition, which is then analyzed by a computer for abnormalities. The technique can screen for oral, cervical and head-and-neck cancers faster and more accurately than current methods, thereby enabling earlier cancer detection, the researchers said.
